Catastrophizing Has a Better Prediction for TMD Than Other Psychometric and Experimental Pain Variables by Willassen, Lisa Celine Fjogstad et al.
Research Article
Catastrophizing Has a Better Prediction for TMD Than Other
Psychometric and Experimental Pain Variables
Lisa Willassen ,1 Anders Arne Johansson ,1,2 Siv Kvinnsland ,1
Kordian Staniszewski ,1 Trond Berge ,1,2 and Annika Rosén 1,2
1Department of Clinical Dentistry, University of Bergen, Bergen, Norway
2Department of Oral and Maxillofacial Surgery, Haukeland University Hospital, Bergen, Norway
Correspondence should be addressed to Annika Rosén; annika.rosen@uib.no
Received 9 May 2020; Revised 21 October 2020; Accepted 24 October 2020; Published 12 November 2020
Academic Editor: Mieszko Wieckiewicz
Copyright © 2020 LisaWillassen et al.*is is an open access article distributed under the Creative Commons Attribution License,
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Temporomandibular disorders (TMDs) are characterized by moderate to severe pain in the masticatory muscles and/or the
temporomandibular joint (TMJ). *e present study is a part of a multidisciplinary project, initiated by the Norwegian Ministry of
Health. *e main purpose of this study is to compare a cohort of TMD patients to healthy individuals regarding experimental
pain, the degree of disability caused by living with pain and psychometric variables, and to investigate which of these variables is
the best predictor for TMD patients. We hypothesised that TMD patients have more disability when living with pain and lower
pain thresholds than healthy controls, and those psychometric variables are stronger predictors than pain thresholds provoked by
experimental pain. Sixty TMD patients were matched by sex and age to sixty healthy individuals without TMD symptoms or other
musculoskeletal symptoms in the head and neck region. All subjects completed a questionnaire that included psychometric
characteristics, that is, a one- and two-item version of the Pain Catastrophizing Scale, the Hospital Anxiety and Depression Scale
(HADS), and the Roland Morris Scale (RMS), which measures disability when living with pain. *ey also underwent a clinical
examination including the measurement of pain thresholds with electrical and pressure stimuli. *e TMD patients had lower pain
thresholds for experimental electrical and pressure stimuli compared with the controls (P< 0.05 and <0.001, respectively). *ey
also scored higher than healthy individuals with disability living with pain (P< 0.001), anxiety (P< 0.001), depression (P< 0.001),
and catastrophizing (P< 0.001). *e results for anxiety, depression, and catastrophizing have been published earlier, and the
reused data in this study are compared with RMS and pain thresholds. *e conditional logistic regression model identified
catastrophizing (OR� 2.42, CI 1.22–4.79) as a significant predictor of TMD patients. *e results support this hypothesis and
indicate that TMD patients have lower pain thresholds andmore disability when living with pain compared to healthy individuals,
where the strongest prediction for TMD was catastrophizing. Awareness of psychometric disabilities in TMD patients is of
importance when considering the choice of treatment.
1. Introduction
*e conditions that cause pain and/or dysfunction of the
temporomandibular joint (TMJ) and muscles that regulate
jaw movements are collectively known as temporoman-
dibular disorder (TMD). In a TMD population, the disorder
is assumed to be at least three times as common in women as
in men [1], while in the general population, TMD is assumed
to be two times as common [2].*e overall prevalence in the
general population is around 3% to 12% among 30- to 50-
year-old individuals [3, 4]. According to a prospective study
of adults in the United States, the annual incidence of TMD
onset is 4% [5]. TMD-related pain usually occurs periodi-
cally over time and can be mild, moderate, or severe. In most
cases of TMD, symptoms can usually be managed with
simple reversible conservative treatment [6]. However, some
patients with painful TMD experience prolonged chronic
pain and reduced function of the masticatory system, both of
which can be treatment-resistant. Prolonged and intense
TMD symptoms may have severe consequences for patients,
including psychological, physical, behavioural, and psy-
chosocial problems [1]. Patients with TMD often have
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impaired mandibular function, with difficulties in jaw
movement such as chewing, yawning, speaking, and even
kissing as the dominant problems. Comorbidities often
occur, particularly general pain conditions, such as other
systemic joint diseases, headaches, and ear and eye pain
[1, 7, 8].
Understanding the source of pain is important for
making a diagnosis and for choosing the appropriate
treatment, which may be conservative, psychological, and/or
surgical [9]. *e pathophysiology of TMD is currently
unknown, but pain amplification (abnormal pain sensitiv-
ity), central sensitisation, and changes in immune activity
have been associated with TMD [10]. A prospective genetic-
based study found that individuals who are more sensitive to
pain have a significantly higher probability of developing
painful TMD than patients who are less sensitive [11].
Sensitivity of tissues can be assessed by measuring
pressure pain thresholds (PPTs) with algometry. It is a valid
and reliable method used to measure the PPT in cranio-
cervical muscles [12]. In tension-type headaches, decreased
pressure pain thresholds over the craniocervical area have
shown to reflect signs of the sensitisation of the trigemi-
nocervical nucleus caudalis [13]. In the orofacial area, ex-
perimental pain, induced by pressure [14–16] or electricity
[17], determines individual pain thresholds or objective
pain. Pressure is used to activate mechanosensitive receptors
and quantify deep muscle pain. Electricity activates non-
nociceptive and nociceptive afferents, affecting tissue that is
more superficial [18]. An electrical stimulus can gradually be
increased, and subjects have to report when the stimulus
changes from a feeling of sensation to a feeling of pain. *is
neurophysiological model of sensitisation of the trigemi-
nocervical nucleus caudalis is generally presumed to play an
important role in the onset and maintenance of migraine
and chronic tension-type headaches [19]. Chronic headaches
are common in TMD, a well-known comorbidity [7]. Pre-
vious studies have shown low pain thresholds in TMD
patients in response to noxious stimuli [20–22].
Questionnaires are often used to assess self-reported
symptoms such as pain (subjective pain) and psychometric
status. Psychosocial factors are suggested as linked to pain-
related disability and duration of pain [23]. Pain is found to
be strongly associated with specific anxiety and depressive
disorders [24], and the presence of anxiety and depression is
found to be associated with higher muscle tenderness in
patients with different types of facial pain [25]. High scores
for anxiety/depression and pain catastrophizing are com-
monly reported in TMD patients [26–28]. Comorbid anxiety
and depressive disorders are associated with disability,
impairment, decreased quality of life, increased health care
utilisations, and substance use in individuals with pain
disorders and symptoms [24].
Patients with TMD, who will undergo TMJ surgery, may
have a high risk of ultimately experiencing postoperative
pain. Among the patients included in this study, seven
patients underwent TMJ surgery, and only one of them was
pain-free at the follow-up [29]. According to the guidelines
from the International Association for the Study of Pain
(IASP), patients with psychological disorders should receive
treatment for such disorders prior to surgery to prevent the
development of persistent postoperative pain. Such pain is
more likely when preoperative pain, fear of pain, expected
pain, and catastrophizing are present [30]. An earlier study
assessed if preoperative psychological testing could predict
the outcome after arthroscopy, and a weak statistically in-
significant association was found between chronic anxiety
and pain in TMD patients after surgery. However, the au-
thors addressed the need for further studies in order to
clarify the role of chronic anxiety for the outcome of TMJ
surgery [31]. Currently, there exist several studies suggesting
the relationship between experimental pain, psychometric
variables, and TMD [5, 32, 33], but to our knowledge, few
studies explore the combined significance of experimental
pain thresholds/psychometric variables regarding TMD. An
earlier study on the same cohort as presented in this study
found higher scorings for anxiety, depression, and cata-
strophizing in TMD patients compared to healthy controls
[34].*ese psychometric data are reused in the present study
in order to perform inferential analyses with new findings
and execute more advanced statistical analysis.
*e main purpose of this study is to compare a cohort of
TMD patients to healthy controls regarding experimental
pain, disability when living with pain and psychometric
variables, and to investigate which of these variables was the
best predictor for TMDpatients.We hypothesised that TMD
patients have more disability when living with pain and
lower pain thresholds than healthy subjects. We further
hypothesised that psychometric variables are stronger pre-
dictors for TMD than pain thresholds provoked by exper-
imental pain.
2. Materials and Methods
Under direction from the Norwegian Directorate of Health,
the Oral and Maxillofacial Surgery Department and the
Clinic for Pain Treatment and Palliation at Haukeland
University Hospital in Bergen, Norway, developed a mul-
tidisciplinary investigation programme for patients with
severe TMD [9].
2.1. Participants. *e participants in this study consisted of
sixty consecutively referred patients with severe TMD and
sixty age- and gender-matched healthy controls. *e study
groups to be characterized were set at sixty patients by the
directive from the health directorate.*e sixty TMD patients
included in the study were referred from their general
medical practitioner during 2013 to 2015 for severe TMD
with long-lasting pain. *e consecutively included patients
were assessed for TMD with a modified DC/TMD, without
using the mandatory command, which has previously been
shown not to impair diagnostic reliability [35]. Inclusion
criteria for admission to the programme included TMD-
related pain in the orofacial area, decreased function of the
jaw, and general disability because of pain. Exclusion criteria
included current substance abuse or severe psychiatric di-
agnoses. Subjective symptoms and clinical signs were
assessed by a multidisciplinary team consisting of specialists
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in oral andmaxillofacial surgery, specialists in orofacial pain,
a pain physician, a psychologist, a physiotherapist, and a
radiologist. *e mean duration of pain for the patients was
11 years. TMD main diagnoses comprised myalgia (n� 22),
arthralgia (n� 1), disc derangement (n� 2), and combina-
tions thereof (n� 35).
Sixty healthy age- and sex-matched subjects without
symptoms of TMD were recruited to serve as a control
group. *e inclusion criteria for the controls were that they
were age- and gender-matched to each of the participants in
the patient group. *e exclusion criteria included TMD
symptoms and pain symptoms in the head and neck. *e
participants in the control group were a convenience sample
selected from the Department of Clinical Dentistry at the
University in Bergen. All included patients and controls
signed a consent form for participating in the study before
the investigations. Two different examiners assessed the
groups, one for the control group and one for the TMD
group. Both examiners underwent specific correlation/
synchronisation training before the clinical assessments.
Recorded details for all patients were stored in their
hospital medical records (DIPS). Data were collected in an
anonymised form.*e project was approved by the Regional
Committee for Medical and Health Professional Research
Ethics (2015/930/REK sør-øst).
2.2. Measurements
2.2.1. Subjective Self-Reported Measurement. All study
participants completed a questionnaire, the Roland Morris
Scale (RMS), and an additional questionnaire assessing
general disability when living with pain [36]. RMS consists of
24 questions/claims as a measure of disability when living
with chronic pain. *e participants marked claims that were
correct with an X (1 point for each claim; maximum
score� 24 points and cut-off� 7 points).
*e psychometric data from the already published study
[34] included the two-item version of Coping Strategies
Questionnaire (CSQ) regarding catastrophizing [37] and the
Hospital Anxiety and Depression scale (HADS) [38]. *e
CSQ included two questions which ranged from 0 to 6
points, where 0 was the lowest score and 6 the highest score
(a total of 6 + 6 points, cut-off >1 for each question). *e
HADS included 7 questions regarding anxiety and 7
questions regarding depression. Each question could be
answered in 4 different ways, ranging from 0 to 3 points (a
total of 21 points and cut-off ≥8 for each condition).
2.2.2. Experimental Pain: Assessment of Sensitivity and Pain
-resholds. To assess pain sensitivity and hyperalgesia,
pressure and electrical stimuli were used. An algometer
assessed pressure pain thresholds (PPTs) on the TMJ, the
masseter muscle, and the finger [39, 40]. *e algometer
(Somedic, Hörby, Sweden) had a probe with a surface area of
1.0 cm2 and a slope of 30 kPa/s. *e algometer was equipped
with a warning signal to prevent overload and a green light
to indicate correct pressure. *e assessment was performed
on the TMJ and the most prominent part of the masseter
muscle, representing local pain. *e patients were asked to
occlude their teeth and then relax their jaw to enable the
examiner to find the most prominent part of the masseter
muscle prior to the algometer measurement. Algometry was
also performed on the tip of the pointing finger, representing
global pain.*e examiner placed the probe on the area being
tested, and as soon as the subject perceived pain (PPT), they
pushed a button to register the exact value of the weight
used. A computer registered and displayed the pressure
value. All tests were performed three times bilaterally, and
the mean of the measured values was recorded.
*e electrical stimuli pain test was performed on the
fingers, as for the algometer, representing global pain. We
included two measurements, specifically electrical sensi-
bility thresholds (ESTs) and electrical pain thresholds
(EPTs), using the PainMatcher (PainMatcher AB, Lund,
Sweden). *e PainMatcher is a microprocessor, which
delivers a constant current of 15mA with monophasic
pulses of 10Hz to the electrodes. Finger press on the
electrode ensures an electrically closed circuit and in-
creased intensity of the pulse, which is sustained for 4 μs to
a maximum of 396 μs [39]. In the first test, subjects were
asked to release the electrode as soon as the stimulus was
felt. In the second test, subjects were asked to release the
electrode as soon as they felt the first feeling of pain from
the stimulus. A number corresponding to the intensity of
the electric stimulus was displayed on the apparatus (score
0–99). *e tests were repeated three times, and the mean
value was calculated.
2.3. Statistical Analyses. Descriptive data were analysed, and
the Wilcoxon signed-rank test was used for bivariate ana-
lyses between TMD cases and controls. *e results from
HADS and catastrophizing have been published earlier as
single independent variables, but the present results are
novel with respect to the adjusted conditional logistic re-
gression [34]. Multivariate conditional logistic regression
using an unadjusted Wald test, and an adjusted one with a
stepwise forward procedure including five variables (PPT in
the masseter muscle/finger and scores from catastrophizing,
depression, and anxiety scales), was performed. Selection
criteria for the independent experimental pain and psy-
chometric variables were of theoretical relevance among the
variables showing significant associations in bivariate
comparisons between TMD cases and controls (Wilcoxon
signed-rank test).
*e data analysis was performed in IBM SPSS Statistics
for Macintosh, version 25.0 (IBM Corp., Armonk, N.Y.,
USA), and Stata Statistical Software: release 14, College




3.1.1. Study Population. *e TMD group had a mean age of
45 years (SD 12.6) and included 51 women and 9 men. *e
mean age of the age- and sex-matched control group was 46
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years (SD 12.6), and it consisted of 51 women and 9 men.
Because some patients dropped out or moved during the
study, we ultimately had a smaller number of participants
and matched pairs (Figure 1): pressure algometer (n� 45),
PainMatcher (n� 58), Roland Morris Scale (n� 59), HADS
(n� 59), and catastrophizing (n� 57).
3.2. Experimental: Assessment of Sensitivity and Pain
-resholds. *e results show that the TMD patients had a
lower PPT than the controls (P � 0.001 for the finger and
masseter muscle and P � 0.003 for the TMJ).
Results from the analysis of the EPT measurements
indicate significant differences between the two groups, with
the TMD patients scoring lower than the controls
(P � 0.014). However, the ESTmeasurements did not differ
significantly between the TMD group and the controls
(Table 1).
3.3. Self-Reported Measurements. *e results from the RMS
showed increased disability for TMD patients compared to
controls (P � 0.001, positive score n� 33 for the patients and
n� 2 for the controls; cut-off P< 0.001). Furthermore, the
TMD patients had more anxiety (P � 0.001, positive score
n� 22 for the patients and n� 5 for the controls; cut-off
P< 0.001), depression (P � 0.001, positive score n� 16 for
the patients and n� 1 for the controls; cut-off P< 0.001) and
catastrophizing (P � 0.001, positive score n� 52 for the
patients and n� 11 for the controls; cut-off P< 0.001)
compared to the controls. Descriptive data are shown in
Table 1. *e results regarding anxiety, depression, and
catastrophizing have previously been published [34]. In this
study, those results were used to perform inferential analyses
with data from the RMS, HADS, and experimental pain in
order to execute more appropriate statistical analyses, i.e.,
conditional regression.
Assessed for eligibility
Controls n = 60 Patients n = 60
Excluded criteria
pressure algometer:
2 = did not want to continue with the
test




1 = did not want to continue with the
test
PainMatcher, Roland Morris Scale:














Figure 1: Flowchart of the study sample.
Table 1: Experimental induced sensitivity or pain thresholds and
scores for disability when living with pain and psychometric








PPT finger 553(235.6) 516.05
402
(178.1) 375.3 0.001
PPT masseter 246(106.3) 211.72
168
(81.4) 167.7 0.001
PPT TMJ 225(112.9) 202.20
157
(69.6) 156.3 0.003
EPT finger 12.94(6.29) 11.50
11.10
(6.27) 10 0.014


















Notes: the Wilcoxon signed-rank test was used for group comparison.
Abbreviations: PPT�pressure pain threshold; TMJ� temporomandibular
joint; EPT�electrical pain threshold; EST�electrical sensibility threshold;
RMS�Roland Morris Disability Questionnaire (0–24p); HADS�Hospital
Anxiety and Depressions Scale. Units: PPT� kPa; EPT/EST� 0–99;
RMS� 0–24p; HADS anxiety� 0–21p; HADS depression� 0–21p;
catastrophizing� 0–12p. ∗*ese results have been published before by
Staniszewski et al. in 2018.
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3.4. Conditional Logistic Regression Analysis. Multivariate
conditional logistic regression using an unadjustedWald test
and an adjusted model using stepwise forward procedure
included five independent variables: PPT in the masseter
muscle and finger as well as scores from catastrophizing,
depression, and anxiety scales. Unadjusted and adjusted
models are shown in Table 2. Adjusted conditional logistic
regression identified catastrophizing (OR� 2.42, CI
1.22–4.79, Table 2) to be the only significant predictor. *e
Nagelkerke was 0.917. *e results from the Wald test and
stepwise forward test regarding catastrophizing did not
appear identical. *is can be explained by a reduced number
of matched pairs in the adjusted analysis due to missing
values in the included independent variables.
4. Discussion
Decreased PPTand higher scorings for psychological factors
in TMD patients compared to healthy controls are well
known in the literature [5, 14, 15, 21, 27, 32, 41, 42], but the
relationship of different factors with predicting TMD pa-
tients is yet to be described. To our knowledge, this study is
the first to analyse the interrelationship between experi-
mental pain thresholds and psychometric variables in re-
lation to TMD by using a multivariate regression model.
*us, our study demonstrates that the catastrophizing has
the best prediction of TMD compared to other psychometric
variables (anxiety and depression) and experimental pain
thresholds (EPT and PPT). In this regard, a previous study
found that high levels of pain catastrophizing increased the
risk of pain and disability in chronic back pain patients [43].
A study by Sorbi et al. using electronic EMS diaries suggests
that both pain intensity and psychological variables explain
disability in chronic pain disorders (CPDs), as well as
substantiate the relevance of psychological functioning for
disability in CPD. *ey found that the prediction of dis-
ability by avoidance behaviour, pain-related fear, and cat-
astrophizing was better compared to pain intensity and
stronger in pain of longer duration than pain of shorter
duration [44]. Another study found that high-pain cata-
strophizing TMDpatients were similar to patients with other
chronic pain conditions and supported the decision to add
scoring for pain catastrophizing to the DC/TMD in order to
identify TMD patients who are at the risk of developing
chronic pain [41]. *e present study supports the afore-
mentioned reports and indicates that catastrophizing might
be of causal importance in the development and persistence
of pain related to TMD. Moreover, it highlights the im-
portance of assessing catastrophizing in the diagnosis and
addressing it in the treatment of TMD.
In addition to the interesting findings in the multivar-
iable analysis, the bivariate analyses showed significant
differences between the TMD group and controls regarding
not only catastrophizing but also anxiety, depression, and
disability when living with pain and experimental sensi-
tivity/pain thresholds. In this regard, it has previously been
suggested that psychological factors are associated with the
development of painful TMD [21], and enhanced pain
sensitivity for experimental pain has been registered in TMD
patients [20]. *e OPPERA study recently published a
community-based cohort study regarding risk factors and
enduring characteristics in TMD patients. *ey studied risk
factors using questionnaires and clinical measures, which
included clinical, health, psychological, behavioural, and
neurosensory domains. Risk factors from the psychological
domain were, among others, anxiety, depression, and cat-
astrophizing. *e results indicate that nearly all risk factors
from all domains increased in patients who developed TMD,
while remaining in patients with persistent TMD and de-
clining in those with transient TMD.*is suggests that TMD
pain onset is determined by enduring characteristics and
changes in biopsychosocial functioning across time [45].
*ese results corroborate our study, which found high
psychological scorings in patients with severe TMD and
long-lasting pain. All of these findings could indicate that the
intensity and duration of TMD are related to the severity and
type of psychological impact and that fluctuations of TMD
symptoms are dependent on psychological mechanisms. To
further evaluate this speculation, future studies should have
a longitudinal design, including a higher number of patients
with different severity and duration of pain and robust
measures of psychological impacts in order to evaluate its
impact on painful TMD.
Previously published data, in the same cohort of patients
as presented in this study, show higher scoring on HADS
and CSQ compared to healthy individuals, as well as higher
Table 2: Unadjusted and adjusted regression analysis of TMD patients.
Independent variables
Unadjusted Adjusted
OR 95% CI for OR P value OR 95% CI for OR P value
PPT finger (n� 45) 0.99 0.99–0.99 0.004 — — —
PPT masseter (n� 47) 0.10 0.01–0.98 0.001 — — —
HADS anxiety (n� 60) 1.23 1.10–1.38 0.001 — — —
HADS depression (n� 59) 1.63 1.27–2.08 0.001 — — —
Catastrophizing (n� 57) 1.90 1.34–2.72 0.001 2.42 1.22–4.79 0.01
Notes: conditional logistic regression including both unadjusted analysis (Wald test) and adjusted (stepwise forward) analysis with temporomandibular
disorders (TMDs) and matched control as dependent variables and with two experimental pain measurements and three self-reported psychometric variables
as independent variables. Nagelkerke R2 � 0.917. Abbreviations: PPT�pressure pain threshold; HADS�Hospital Anxiety and Depression Scale; n�number
of individuals included in the analysis; SD� standard deviation; OR� odds ratio; units: PPT� kPa; HADS anxiety� 0–21p; HADS depression� 0–21p;
catastrophizing� 0–12p.
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levels of cortisol in the saliva, showing an upregulated HPA
axis indicating higher levels of stress [34]. *ese findings are
also supported by others who have found that stress is a
strong predictor of TMD pain [46]. Canales et al. found high
tomoderate levels of depression and somatisation in patients
with TMD [47], and it has been established that concurrent
depression and pain have a greater impact on chronic pain
disorder than pain disorders alone [42]. Greater pain in-
tensity, longer duration of pain, persistent pain, impaired
social functioning, and the likelihood of poor treatment
outcome are seen when depression and pain coexist [48]. A
similar study assessing the potential role of biological,
psychological, and social factors in order to predict the
presence of painful TMD using multivariate analysis found a
relationship between TMD pain and depression, which
supports the need of considering both psychological factors
in relation to TMD signs and symptoms [27].
An association between psychological distress, a lower
threshold in experimentally induced pain, and painful TMD
has been found [5] in analogy with the present study.
Not unexpectedly, the TMD patients in the present study
had more tenderness measured by the PPT, and previous
studies have reported greater sensitivity to experimental
pain because of alterations in endocrine, sensory, and
psychological processes, as well as central sensitisation
[49, 50]. In tension-type headaches andmigraines, decreased
PPT in the trapezius muscle and suboccipital sites reflect
altered pain perception and support the pathophysiological
model of sensitisation [51]. On the contrary, Stuginski-
Barbosa et al. [33] found a statistically weak correlation
between pain intensity (shown on a visual analogue scale)
and PPT (measured by an algometer) in TMD patients with
arthralgia, suggesting that other factors, such as nociceptive
processes in the central nervous system and additional
psychological factors, are important in explaining pain in
TMD patients. *e difference in PPT between the TMD
patients and controls in our study might have an association
with the high psychological impact in the TMD group.
*e surgically treated patients in this cohort, published
in 2017, had high scoring of catastrophizing and postop-
erative pain [29], possibly due to surgical fear, expected pain,
and preoperative pain [30, 52]. *e suggestion that cata-
strophizing might be a predictive factor for persistent
postoperative pain [30] may be supported by our study,
which shows that the same cohort of patients who had poor
surgical outcomes [29] also scored high on catastrophizing.
If so, screening the patient’s psychological status and pre-
operative treatment of such disorders may be necessary to
avoid persistent postoperative pain.
Our study had several limitations. First, most of the
participants in the control group were selected from the
Department of Clinical Dentistry at the University of Bergen
and were acquainted with the examiner who evaluated them.
*e acquaintance between the subjects and the examiner
may have affected measurements and given rise to bias. A
second limitation was that the exclusion criteria did not
include other chronic pain disorders and neurological dis-
orders that might have affected the pain perception or
medications such as paracetamol, NSAID’s, opioids, and
antidepressants that might have affected the pain threshold
as well as anxiety and depressive symptoms. Since the pa-
tients were recruited consecutively by referrals to the Na-
tional TMD project at Haukeland University Hospital, other
chronic pain disorders, neurological disorders, or medica-
tions used by the patients were not considered during the
recruitment process but were scrutinized during the thor-
ough multidisciplinary investigation by six different spe-
cialists. If there was a need of additional specialist
investigation, the patients were further referred before the
summation of the investigation was presented for the pa-
tient. A third major limitation was that there were two
different examiners, one examiner for the control group and
one for the TMD patient group. *e examiners were trained
prior to the examination of participants to minimise vari-
abilities and achieve acceptable interexaminer reliability.
Nevertheless, there may still have been interexaminer dif-
ferences that could have affected the results. A fourth
limitation was the drop-out of participants in the algometer
test due to either no assessments or healthy individuals not
wanting to be exposed to the algometer. A final limitation is
that the RMS is originally a questionnaire for low-back pain
patients, but since it shows disability when living with pain,
and because the questions can apply to any type of body
pain, it should not affect the validity. An additional short-
coming is that part of the results was published earlier, the
psychometric data, but at this time using single independent
variables [34]. *is can affect the results to be not that
relevant or less novel. But after using more advanced sta-
tistical analysis which strengthened the results, we found it
motivated to let the results be disseminated via a research
publication.
5. Conclusions
To conclude, the TMD patients have lower pain thresholds
and a higher disability of pain compared to healthy indi-
viduals. *e strongest prediction for TMD was cata-
strophizing. *ese results are important to be considered
when managing TMD patients. Awareness of psychometric
disabilities in TMD patients is of importance and should be
addressed in the treatment plan.
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